BTSGU News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

Loading chart

Pay with

BT

Mkt Cap

N/A

Volume

1.31K

Next Earnings

N/A

Chart Financials Earnings News About Dividends Insider Filings

BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?BrightSpring Health Services (BTSG) has surged 67.3% year-to-date, outperforming broader markets, driven by strong growth in Specialty and Infusion revenues (up 32.7%) and Provider Services (up 29.1%). The company raised its 2026 outlook twice and improved leverage to 2.15x after divesting its Community Living business. However, a $200M IRA impact on Home and Community Pharmacy and integration execution risks present headwinds. Analysts rate BTSG as a Hold.Zacks Investment Research · Oct 14, 2026

Top Stock Reports for Oracle, American Express & ProgressiveZacks analysts published research on 16 major stocks on October 12, 2026. Oracle faces headwinds from negative free cash flow and intense cloud competition but benefits from AI demand. American Express shows strong spending and customer acquisition despite rising expenses. Progressive maintains a neutral stance due to normalizing auto pricing and valuation concerns. Additional coverage includes Western Midstream, BrightSpring Health, and Dr. Reddy's Laboratories.Zacks Investment Research · Oct 12, 2026

3 Carillon Mutual Funds to Consider Amid Evolving Economic TrendsThe article examines Carillon Mutual Funds as an alternative to larger mutual fund families, highlighting their diversified lineup and active management strategies. Three funds are recommended based on Zacks rankings and performance metrics: Carillon Eagle Small Cap Growth (HSIIX), Carillon Clarivest International Stock (EISIX), and Carillon Chartwell Small Cap (UMBHX). All three funds offer positive multi-year returns and low expense ratios, though investors are cautioned to consider expenses, risk, and performance consistency before investing.Zacks Investment Research · Oct 8, 2026

BTSG Deploys AI Across Operations: Will It Improve Margins?BrightSpring Health Services is leveraging AI and automation across hiring, intake, documentation, and patient care to improve productivity. The company reported 44% year-over-year adjusted EBITDA growth with margin expansion to 5.3%, with further benefits expected in late 2026 and early 2027. Peers Option Care Health and Addus HomeCare are similarly implementing AI-driven initiatives to enhance efficiency and reduce operational complexity.Zacks Investment Research · Sep 30, 2026

BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?BrightSpring Health Services (BTSG) receives a #2 (Buy) rating from Zacks with an A VGM Score and B Value Style Score. The company, a national home and community-based healthcare services provider, has seen three analysts revise earnings estimates upward in the last 60 days, with consensus estimates increasing to $1.82 per share and an average earnings surprise of +16.1%.Zacks Investment Research · Sep 30, 2026

Zacks.com featured highlights include Centene, BrightSpring Health Services and Delek USFollowing a sharp market rally driven by declining oil prices and AI-related stocks, Zacks highlights three momentum stocks with strong year-to-year gains but recent weekly pullbacks: Centene Corp., BrightSpring Health Services, and Delek US Holdings. All three stocks have Momentum Score A ratings and are positioned as potential beneficiaries of momentum investing strategies despite geopolitical tensions in the Middle East.Zacks Investment Research · Sep 23, 2026

3 Momentum Anomaly Stocks to Buy as Markets Surge on AI RallyThree healthcare and energy stocks with strong 52-week gains have experienced recent weekly declines. Centene, BrightSpring, and Delek US Holdings all posted gains between 98-129% over the past year but fell 0.1-7.4% in the past week, exemplifying a momentum investing strategy that capitalizes on short-term pullbacks in long-term winners.Zacks Investment Research · Sep 22, 2026

BTSG Faces $200M IRA Hit but Efficiency May Protect ProfitabilityBrightSpring Health Services' Home and Community Pharmacy segment experienced an 8% revenue decline to $540M in Q2, with the Inflation Reduction Act (IRA) accounting for approximately $50M of the impact. Despite a projected $200M revenue headwind in 2026 from IRA pricing changes, the company expects only a $15M EBITDA impact, demonstrating that operational efficiency gains from technology, automation, AI, and Lean initiatives are offsetting regulatory pressures. Peer companies Cardinal Health and CVS Health are similarly navigating IRA-driven revenue pressures while maintaining profitability through service agreements and operational improvements.Zacks Investment Research · Sep 17, 2026

Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?Cardinal Health expects fiscal 2027 IRA pricing changes to create similar revenue headwinds as 2026, but management aims to preserve compensation and maintain profitability through distribution agreements and operational efficiency. Peers BrightSpring and CVS Health also face IRA-related revenue pressure but are offsetting impacts through operational improvements and specialty pharmacy growth.Zacks Investment Research · Sep 16, 2026

IQVIA Stock Rises 60% in 6 Months: Here's What You Should KnowIQVIA (IQV) has surged 60.1% over six months, driven by 6% organic growth in Q2 2026, with R&DS bookings up 19.3% and a $34.2 billion backlog. The company's rapid AI adoption—294 agents deployed across 90 use cases with 19 of top 20 pharma companies adopting solutions—is strengthening its competitive position and supporting sustained growth.Zacks Investment Research · Sep 16, 2026

to start trading

BT

BTSGUBrightSpring Health Services, Inc. Tangible Equity Unit

BTSGU

Pay with—

Available Balance0.00

Your PositionYou don't own any BTSGU yet.

Related Tickers

Earnings

Dividends

Last · Oct 15Quarterly

Amount$0.84

Yield1.69%

Annual$3.38